Status:
UNKNOWN
Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer
Lead Sponsor:
Mansoura University
Conditions:
Non-Muscle Invasive Bladder Cancer
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The investigators hypothesize that omega-3 polyunsaturated fatty acids (n-3 PUFAs) might have a role in prevention of the recurrence of non-muscle invasive bladder cancer (NMIBC). The patients who ar...
Detailed Description
The investigators hypothesize that omega-3 polyunsaturated fatty acids (n-3 PUFAs) might have a role in prevention of the recurrence of non-muscle invasive bladder cancer (NMIBC). The patients who ar...
Eligibility Criteria
Inclusion
- \- Patients who are at high risk for recurrence of NMIBC after TURBT based on the following tumor characteristics:
- Stage Ta (G3, multifocal, or ≥ 2 occurrences within 12 months, including the current tumor),
- Stage T1 (any grade) and/or,
- Carcinoma in situ (CIS),
- Without any indication for radical cystectomy.
Exclusion
- \- Patients with:
- ≥ T2 bladder cancer,
- Evidence of nodal metastasis,
- Associated upper tract urothelial carcinoma (UTUC) or
- Those who refuse.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04664816
Start Date
December 1 2020
End Date
December 1 2023
Last Update
December 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center, Mansoura University
Al Mansurah, Egypt